Related Experiment Video
Updated: Mar 6, 2026
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.6K
Curcumin Nanotechnologies and Its Anticancer Activity
Parasuraman Aiya Subramani1,2, Kalpana Panati3, Venkata Ramireddy Narala1
1a Department of Zoology , Yogi Vemana University , Kadapa , India.
Nutrition and Cancer
|March 14, 2017
Summary
Curcumin shows anticancer promise, but poor bioavailability limits clinical success. Nanoparticle drug carriers significantly enhance curcumin
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Cancer remains a leading global cause of mortality.
- Curcumin exhibits potent in vitro anticancer properties.
- Poor bioavailability hinders clinical efficacy of curcumin treatments.
Purpose of the Study:
- To review nanotechnology-based strategies for enhancing curcumin bioavailability.
- To explore diverse nanoparticle formulations for curcumin delivery.
- To discuss future research directions for curcumin nanoparticles.
Main Methods:
- Review of existing literature on curcumin nanoparticles.
- Categorization of nanotechnologies based on complexity and function.
- Analysis of curcumin-metal complexes and thermoresponsive nanoparticles.
Main Results:
- Nanoparticle drug carriers effectively improve curcumin bioavailability.
- Curcumin-metal complexes represent a simple yet effective nanoparticle form.
- Advanced systems like thermoresponsive nanoparticles offer controlled release mechanisms.
Conclusions:
- Nanotechnology offers viable solutions to overcome curcumin's bioavailability challenges.
- Development of novel curcumin nanoparticles is crucial for clinical translation.
- Further research is needed to optimize potent curcumin nanoparticle formulations.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:10Drugs that Destabilize Microtubules
4.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K